| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Carolyn Doree | Q28036971 |
| Sheila A Fisher | Q90255462 | ||
| Enca Martin-Rendon | Q123361841 | ||
| P2093 | author name string | Anthony Mathur | |
| Huajun Zhang | |||
| P2860 | cites work | Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 |
| Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis | Q22306551 | ||
| Stem cell therapy for chronic ischaemic heart disease and congestive heart failure | Q24194988 | ||
| Stem cell treatment for acute myocardial infarction | Q24203736 | ||
| Stem cell treatment for acute myocardial infarction | Q24240868 | ||
| Stem cell treatment for acute myocardial infarction | Q24245860 | ||
| Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis | Q24289436 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis | Q27001633 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) | Q28216990 | ||
| Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 | ||
| Cell therapy for cardiac repair--lessons from clinical trials. | Q30359782 | ||
| Randomized trials published in some Chinese journals: how many are randomized? | Q30489085 | ||
| Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction | Q30824170 | ||
| Transcoronary transplantation of progenitor cells after myocardial infarction | Q30824315 | ||
| Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy | Q30883977 | ||
| Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data | Q30896351 | ||
| Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomized-controlled BOOST trial--an echocardiographic study | Q30926984 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial | Q31033745 | ||
| Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Q31113632 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial | Q33151955 | ||
| Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging | Q33193903 | ||
| Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial | Q33235180 | ||
| Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial | Q33263365 | ||
| Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells an | Q33290353 | ||
| Individual differences in the effectiveness of intracoronary bone marrow cell transplantation assessed by gated sestamibi SPECT/FDG PET imaging | Q33339070 | ||
| Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year | Q50695217 | ||
| Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function | Q50774320 | ||
| Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. | Q50776586 | ||
| Cell therapy in patients with left ventricular dysfunction due to myocardial infarction. | Q50778701 | ||
| Stem cells show mixed results in MI patients | Q51152880 | ||
| The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction | Q51363566 | ||
| Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction | Q51618016 | ||
| Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study | Q51804556 | ||
| CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent | Q53254720 | ||
| Transplantation with autologous mesenchymal stem cells after acute myocardial infarction evaluated by magnetic resonance imaging: an experimental study | Q53266564 | ||
| A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery | Q53302996 | ||
| Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). | Q53316434 | ||
| Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction | Q53558634 | ||
| Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. | Q54611816 | ||
| Cell-based therapy for myocardial repair in patients with acute myocardial infarction: Rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI) | Q54806428 | ||
| MRI strain analysis as a novel modality for the assessment of myocardial function following stem cell therapy-results from Amorcyte trial. | Q55469875 | ||
| Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial | Q56610959 | ||
| Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction | Q57484933 | ||
| Rapid Initial Reduction of Hyperenhanced Myocardium After Reperfused First Myocardial Infarction Suggests Recovery of the Peri-Infarction Zone | Q57572158 | ||
| COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients After Acute Myocardial Infarction and Left Ventricular Dysfunction: Study Rationale and Design | Q57951477 | ||
| Stem Cell Therapy for the Broken Heart: Mini-Organ Transplantation | Q57951496 | ||
| Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study | Q58071326 | ||
| Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocar | Q58071404 | ||
| Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial | Q58816253 | ||
| The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart | Q58816259 | ||
| Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled | Q59260969 | ||
| Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial | Q59261024 | ||
| Time-Dependent Effects on Coronary Remodeling and Epicardial Conductance after Intracoronary Injection of Enriched Hematopoietic Bone Marrow Stem Cells in Patients with Previous Myocardial Infarction | Q61651473 | ||
| Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction | Q61675842 | ||
| Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int | Q61942700 | ||
| Autologus transplantation of mononuclear bone marrow cells after acute myocardial infarction: A PILOT study | Q62109407 | ||
| TCT-823 Results from LateTIME: A Randomized, Placebo Controlled Trial of Intracoronary Stem Cell Delivery Two to Three Weeks Following Acute Myocardial Infarction from the Cardiovascular Cell Therapy Research Network | Q62632874 | ||
| Autologous bone-marrow stem-cell transplantation for myocardial regeneration | Q78761519 | ||
| Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimul | Q79257408 | ||
| Intracoronary autologous bone marrow cell transplantation beneficially modulates heart rate variability | Q79269791 | ||
| Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in My | Q79615200 | ||
| Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial | Q79770846 | ||
| The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI) | Q79843933 | ||
| Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial | Q80147524 | ||
| Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction | Q80246358 | ||
| Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study | Q80485648 | ||
| Cell therapy in myocardial infarction | Q80553698 | ||
| Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow- | Q80665059 | ||
| Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects | Q81191191 | ||
| Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes | Q81234350 | ||
| Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized | Q81346953 | ||
| Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of | Q82294838 | ||
| Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1 | Q82470535 | ||
| Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study | Q83076047 | ||
| Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study | Q83115535 | ||
| Exercise capacity, arrhythmic risk profile, and pulmonary function is not influenced by intracoronary injection of bone marrow stem cells in patients with acute myocardial infarction | Q83582870 | ||
| Autologous mononuclear bone marrow cells during reparative regeneratrion after acute myocardial infarction | Q83941697 | ||
| Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarction | Q84825127 | ||
| Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure | Q84940240 | ||
| Systolic function of patients with myocardial infarction undergoing autologous bone marrow transplantation | Q84948217 | ||
| The short to mid-term effect of bone marrow derived cell transfer on diastolic function after acute myocardial infarction | Q84971839 | ||
| Intracoronary infusion of bone-marrow derived mononuclear cells in acute myocardial infarction: are outcomes influenced by the number of infused cells? | Q85783128 | ||
| A critical challenge: Dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction | Q86733086 | ||
| Two year follow-up results of the CARDIAC (CARDIomyoplasty by Autologous intraCoronary bone marrow in acute myocardial infarction) randomised controlled trial | Q87338481 | ||
| The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction | Q88176971 | ||
| A Randomized, Double‐blind, Placebo‐controlled, Dose‐escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction (AMI) | Q94553032 | ||
| Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation. | Q36117569 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction - MiHeart/AMI study | Q36793619 | ||
| Myocardial regeneration and stem cell repair | Q37075439 | ||
| Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction | Q37294647 | ||
| Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up | Q37305343 | ||
| Long-term trends in the incidence of heart failure after myocardial infarction | Q37312662 | ||
| Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction | Q37444118 | ||
| A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction | Q37473636 | ||
| A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI). | Q37598059 | ||
| Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction) | Q37625636 | ||
| Cells as biologics for cardiac repair in ischaemic heart failure | Q37744280 | ||
| Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis | Q38021450 | ||
| Cell therapy in reperfused acute myocardial infarction does not improve the recovery of perfusion in the infarcted myocardium: a cardiac MR imaging study | Q38195091 | ||
| Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function | Q38452784 | ||
| One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133 Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction. | Q38803500 | ||
| Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials | Q39222871 | ||
| REPAIR-AMI: stem cells for acute myocardial infarction | Q40238928 | ||
| Coronary Plaque Disruption | Q40459835 | ||
| Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl | Q40525372 | ||
| Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation | Q40611732 | ||
| Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe? | Q41540357 | ||
| Stem cell therapy for myocardial infarction | Q42388251 | ||
| Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial | Q42493083 | ||
| Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques | Q42625888 | ||
| The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection | Q42812946 | ||
| Influence of intracoronary injections of bone-marrow-derived mononuclear cells on large myocardial infarction outcome: quantum of initial necrosis is the key. | Q43186049 | ||
| Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results | Q43215597 | ||
| Updating meta-analyses leads to larger type I errors than publication bias | Q43783542 | ||
| Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarction | Q43994483 | ||
| Intracoronary infusion of mononuclear bone marrow-derived stem cells is associated with a lower plaque burden after four years | Q44976551 | ||
| Effects of stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction | Q46856985 | ||
| Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction | Q46989780 | ||
| Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial | Q47388203 | ||
| Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction | Q48831721 | ||
| Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review | Q33340205 | ||
| Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. | Q33374961 | ||
| Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated 99mTc-MIBI single-photon emission computed tomography study | Q33389025 | ||
| Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenit | Q33413306 | ||
| Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction | Q33440102 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial | Q33505911 | ||
| Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial in | Q33507496 | ||
| Results of intracoronary stem cell therapy after acute myocardial infarction | Q33538384 | ||
| Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy | Q33546217 | ||
| Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction | Q33687920 | ||
| Long-term results of intracoronary bone marrow cell transplantation: the potential of gated sestamibi SPECT/FDG PET imaging to select patients with maximum benefit from cell therapy | Q33691243 | ||
| Effects of intracoronary injection of autologous bone marrow-derived stem cells on natriuretic peptides and inflammatory markers in patients with acute ST-elevation myocardial infarction. | Q33720841 | ||
| Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial | Q33762062 | ||
| Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy | Q33919886 | ||
| Maladaptive hypertrophy after acute myocardial infarction positive effect of bone marrow-derived stem cell therapy on regional remodeling measured by cardiac MRI. | Q33935106 | ||
| Encouraging experience with intracardiac transplantation of unselected autologous bone marrow cells concomitant with coronary artery bypass surgery after myocardial infarction. | Q34006856 | ||
| Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial | Q34074673 | ||
| The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction | Q34257083 | ||
| Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes | Q34288961 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial | Q34453706 | ||
| Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial | Q34467911 | ||
| Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of ⁹⁹(m)Tc-labeled cells activity | Q34544884 | ||
| A multicenter, prospective, randomized, controlled trial evaluating the safety and efficacy of intracoronary cell infusion mobilized with granulocyte colony-stimulating factor and darbepoetin after acute myocardial infarction: study design and ratio | Q34610877 | ||
| One-year follow-up of intracoronary stem cell delivery on left ventricular function following ST-elevation myocardial infarction | Q34723525 | ||
| Regional myocardial function after intracoronary bone marrow cell injection in reperfused anterior wall infarction - a cardiovascular magnetic resonance tagging study | Q34743695 | ||
| Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. | Q34807168 | ||
| Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: final results from the randomized, double-blind, placebo controlled intracoronary Stem Cell therapy in patients with Acute Myocardial Infarction ( | Q34879592 | ||
| Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction | Q35070840 | ||
| Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival | Q35102931 | ||
| Meta-analysis of cell therapy trials for patients with heart failure | Q35551127 | ||
| Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial | Q35574281 | ||
| Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). | Q35772741 | ||
| P921 | main subject | acute myocardial infarction | Q18558122 |
| myocardial infarction | Q12152 | ||
| P577 | publication date | 2015-09-30 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Stem cell treatment for acute myocardial infarction |
| Q37698929 | Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review |
| Q93089068 | Application of Bioengineered Materials in the Surgical Management of Heart Failure |
| Q42001387 | Approaches to augment vascularisation and regeneration of the adult heart via the reactivated epicardium |
| Q55348173 | Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials. |
| Q90588199 | Cardiac Cell Therapy Rejuvenates the Infarcted Rodent Heart via Direct Injection but Not by Vascular Infusion |
| Q49353094 | Cardiac stem cell trials and the new world of cellular reprogramming: Time to move on. |
| Q57072502 | Changing Metabolism in Differentiating Cardiac Progenitor Cells-Can Stem Cells Become Metabolically Flexible Cardiomyocytes? |
| Q88105650 | Concepts, Utility and Limitations of Cord Blood Banking: What Clinicians Need to Know |
| Q39347586 | Concise Review: Criteria for Chamber-Specific Categorization of Human Cardiac Myocytes Derived from Pluripotent Stem Cells |
| Q37613088 | Direct Cardiac Cellular Reprogramming for Cardiac Regeneration |
| Q26739729 | Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literature |
| Q58115995 | Effect of equiaxial cyclic strain on cardiomyogenic induction in mesenchymal stem cells |
| Q64104219 | Effect of stem cell transplantation on patients with ischemic heart failure: a systematic review and meta-analysis of randomized controlled trials |
| Q41425103 | Effects of Endothelial and Mesenchymal Stem Cells on Improving Myocardial Function in a Sheep Animal Model |
| Q29994502 | Fifteen years of bone marrow mononuclear cell therapy in acute myocardial infarction |
| Q46247702 | Geraniin protects bone marrow‑derived mesenchymal stem cells against hydrogen peroxide‑induced cellular oxidative stress in vitro |
| Q89870117 | Heart regeneration in mouse and human: A bioengineering perspective |
| Q64946838 | Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction. |
| Q91790333 | In Vivo MRI Tracking of Mesenchymal Stromal Cells Labeled with Ultrasmall Paramagnetic Iron Oxide Particles after Intramyocardial Transplantation in Patients with Chronic Ischemic Heart Disease |
| Q52730314 | Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-analysis |
| Q42333634 | Mesenchymal stromal cell therapy as treatment for ischemic heart failure: the MSC-HF study |
| Q47140141 | MiRroring the Multiple Potentials of MicroRNAs in Acute Myocardial Infarction |
| Q93069246 | Optimization of Timing and Times for Administration of Atorvastatin-Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction |
| Q55261793 | Pericardial application as a new route for implanting stem-cell cardiospheres to treat myocardial infarction. |
| Q38376997 | Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function |
| Q37735796 | Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review |
| Q39148627 | Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality. |
| Q91705325 | Protective Effect Of Vasicine Against Myocardial Infarction In Rats Via Modulation Of Oxidative Stress, Inflammation, And The PI3K/Akt Pathway |
| Q49288386 | Pursuing meaningful end-points for stem cell therapy assessment in ischemic cardiac disease. |
| Q36262927 | Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials |
| Q54988738 | Retention and Functional Effect of Adipose-Derived Stromal Cells Administered in Alginate Hydrogel in a Rat Model of Acute Myocardial Infarction. |
| Q47697828 | Retrograde Coronary Venous Infusion as a Delivery Strategy in Regenerative Cardiac Therapy: an Overview of Preclinical and Clinical Data |
| Q64947688 | Safety and Efficacy of Adult Stem Cell Therapy for Acute Myocardial Infarction and Ischemic Heart Failure (SafeCell Heart): A Systematic Review and Meta-Analysis. |
| Q92691743 | Scientific Papers and Patents on Substances with Unproven Effects. Part 2 |
| Q90372519 | Stem Cell Therapies in Cardiovascular Disease |
| Q28069300 | Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet? |
| Q30239945 | Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. |
| Q64117179 | Stem cell-derived extracellular vesicles for myocardial infarction: a meta-analysis of controlled animal studies |
| Q52724750 | Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial. |
| Q28077893 | Strategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial Infarction |
| Q61804583 | Sufficient therapeutic effect of cryopreserved frozen adipose-derived regenerative cells on burn wounds |
| Q48228018 | Therapeutic benefits of CD90-negative cardiac stromal cells in rats with a 30-day chronic infarct. |
| Q39128194 | Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. |
Search more.